Profil
Kate E.
Broderick is Senior Vice President-Research & Development at TriLink BioTechnologies LLC since 2022.
Formerly, Dr. Broderick was Senior Vice President-Research & Development at Inovio Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Broderick was Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. from 2022 to 2025.
Dr. Broderick earned a doctorate from the University of Glasgow.
Postes actifs de Kate Broderick
| Sociétés | Poste | Début |
|---|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Anciens postes connus de Kate Broderick
| Sociétés | Poste | Fin |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2025 |
| INOVIO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2022 |
Formation de Kate Broderick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
















